GLP-1 Injection Site Reactions: Lumps & Bruising

Medically reviewed by Amber Patel, MD · Last updated July 15, 2026. Nouri content is reviewed by licensed clinicians and updated as guidance changes.

Are lumps at the injection site normal?

Usually, yes. A small, soft lump or bubble right after you inject is simply the medication sitting in the fatty tissue before it disperses and absorbs — it typically flattens within a few hours to a couple of days. Injecting too shallowly (into the skin rather than the fat beneath it) can make that bump more noticeable and slower to fade, which is one reason technique matters.

The lump worth paying attention to is the firm, rubbery one that keeps coming back in the same area. That's often lipohypertrophy — a buildup of fat and scar tissue caused by repeatedly injecting the same spot, reusing needles, or not rotating sites. It's well documented in people who inject insulin, and the same physics apply to a GLP-1. These lumps aren't dangerous, but they can make absorption less predictable, and the fix isn't a cream — it's resting that area for two to three months while you inject elsewhere. A separate, less common cause is an inflammatory nodule: a published case report described hard, itchy, quarter-sized nodules appearing shortly after semaglutide injections at the maximum dose, resolving within a few days. It's documented but uncommon. Any lump that grows, hardens over days, or doesn't resolve over weeks is one to show your care team.

Why do I bruise at the injection site?

Bruising happens when the needle nicks a small blood vessel under the skin and a little blood leaks into the tissue. It's harmless and fades over a few days. You're more likely to bruise if you take blood thinners (like warfarin or apixaban), aspirin, or fish oil, if you're dehydrated, or if you inject into a spot you used recently. To reduce it:

• Let the medication reach room temperature before injecting — cold liquid stings more and makes vessels more fragile. (If you're wondering how long it can sit out, see our guide on whether semaglutide needs refrigeration.)
• After you pull the needle out, apply gentle pressure for several seconds — don't rub. Rubbing spreads the medication and worsens bruising. If you're on a blood thinner, hold pressure a little longer.
• Rotate sites so you're not re-traumatizing the same tissue.

Bruising that's large and expanding, or paired with a growing hard lump or signs of infection, is worth a message to your care team.

What about redness, itching, and swelling?

Mild redness, itching, or a little firmness right at the injection site is a common local reaction and usually settles within a day or two. In the clinical trials behind the FDA-approved products, these reactions were uncommon and mild: about 1.4% of people taking semaglutide (Wegovy) versus 1% on placebo, and about 3.2% to 7.1% of people taking tirzepatide (Zepbound), rising with the dose, versus 1.8% on placebo — with none reported as severe. Those figures are for the branded, FDA-approved molecules studied in the trials; compounded semaglutide and tirzepatide are not FDA-approved and haven't been evaluated the same way, so treat the rates as a general reference, not a guarantee.

What's not a routine local reaction is anything spreading or systemic. A rash that grows, widespread hives, or — most urgently — swelling of the face, lips, or throat or any trouble breathing can signal a serious allergic reaction and is a medical emergency. Those are covered next.

When should you worry about an injection-site reaction?

The line between "normal and fading" and "get it checked" comes down to whether the reaction is local and improving or spreading and worsening. Contact your care team promptly — these can signal an infection or abscess:

• Redness that spreads outward from the site, or red streaks tracking away from it
• Increasing warmth, throbbing pain, or a swelling that feels soft and fluid-filled
• Pus or drainage, or a yellow/white center
• Fever, chills, or feeling generally unwell — a normal local reaction doesn't do this
• A lump that grows or hardens over days, or a nodule that won't resolve over weeks

Call 911 or go to the emergency room for signs of a serious allergic reaction: hives, swelling of the face, lips, tongue, or throat, throat tightness, or difficulty breathing. These are rare, but they're immediate emergencies.

How to prevent injection-site reactions

Most lumps and bruises come down to two habits — rotating your sites and using a fresh needle — plus a few small technique points. GLP-1s are injected into the fat just under the skin at one of three areas: the abdomen (staying at least two inches from your navel), the front of the thigh, or the back of the upper arm.

• Rotate every injection. Move to a different spot each week, keeping injections at least a finger-width apart, and give any area a rest before returning to it. This is the single best defense against lumps and lipohypertrophy.
• Use a new needle every time. Reused needles are dull, which increases tissue trauma, bruising, and lumps.
• Let the alcohol dry before you inject — wet alcohol stings and irritates the skin.
• Inject at the right depth — pinch a fold of skin and insert at 90 degrees (or 45 if you have little fatty tissue) so the medication reaches the fat, not the surface layer.
• Gentle pressure after, no rubbing.

Compounded vials, needles, and technique

If your GLP-1 comes as a multi-dose vial you draw with an insulin syringe — as compounded semaglutide and tirzepatide usually do — a fresh needle each dose matters even more, since drawing from a vial and then injecting can dull a reused needle quickly. The bigger compounded-specific safety point isn't the skin reaction, though; it's drawing the correct dose. The FDA has warned about serious dosing errors when people confuse milligrams, milliliters, and syringe units and draw five to twenty times their intended dose from a vial. Always inject the exact number of units your prescriber specified for your vial's concentration — our tirzepatide dose calculator and semaglutide dose calculator convert a prescribed dose to units for any concentration, and if anything looks different from last time, confirm with your care team before injecting. For the broader picture of what to expect, see our guide to tirzepatide side effects.

Frequently asked questions

Why do I get a lump after my semaglutide injection?

A small lump right after injecting is usually just the medication sitting in the fatty tissue before it disperses — it typically settles within hours to a couple of days. A firm lump that keeps returning in the same spot is often lipohypertrophy from repeatedly injecting there; rotating sites and using a fresh needle prevents it.

Is bruising after a GLP-1 injection normal?

Yes — bruising happens when the needle nicks a small blood vessel, and it fades over a few days. It's more likely if you take blood thinners, aspirin, or fish oil. Apply gentle pressure without rubbing, and rotate sites to reduce it.

How do I stop injection-site bruising?

Inject at room temperature, apply gentle pressure for several seconds afterward instead of rubbing (longer if you're on a blood thinner), rotate to a fresh site each time, and use a new needle. Persistent large or expanding bruises are worth a message to your care team.

What is a hard lump at the injection site?

A firm, rubbery lump that recurs in the same area is often lipohypertrophy — a buildup of fat and scar tissue from repeated same-spot injections and needle reuse. It's not dangerous but can affect absorption; the fix is resting that area for two to three months and injecting elsewhere.

How long do injection-site lumps last?

A normal post-injection lump usually flattens within hours to a few days. A lipohypertrophy lump can persist for weeks or months and needs the area rested to heal. Any lump that grows, hardens over days, or doesn't resolve over weeks should be evaluated.

When should I worry about an injection-site reaction?

Contact your care team for spreading redness, red streaks, increasing warmth or pain, pus, fever, or a lump that grows over days — possible signs of infection. Call 911 for hives, face or throat swelling, or trouble breathing, which can signal a serious allergic reaction.

Sources

• Wegovy (semaglutide) Prescribing Information — injection-site reaction rate and subcutaneous administration. rxlist.com
• Zepbound (tirzepatide) — incidence of injection-site reactions in the SURMOUNT studies (Eli Lilly Medical). medical.lilly.com
• Cleveland Clinic — How To Give Yourself a Subcutaneous Injection (sites, technique, rotation). clevelandclinic.org
• Cleveland Clinic — Lipohypertrophy (cause, prevention, management). my.clevelandclinic.org
• MedlinePlus (NIH) — Subcutaneous (SQ) injections. medlineplus.gov
• Hearn EB, Sherman JJ. Injection-Site Nodules Associated With Once-Weekly Subcutaneous Semaglutide. Diabetes Spectrum 2021. pmc.ncbi.nlm.nih.gov
• FDA — Dosing errors associated with compounded injectable semaglutide (July 2024). fda.gov
• FDA — FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. fda.gov

Starting or switching your GLP-1 care? See if you qualify with Nouri — a U.S.-licensed physician reviews your intake, and your Care Team is a message away for questions like these. One all-inclusive price, the same at any dose.

This article is educational and is not medical advice; it describes general injection-site reactions and FDA-approved product labels, and it is not a substitute for your prescriber's or pharmacy's specific instructions. Compounded semaglutide and tirzepatide are not FDA-approved and are not therapeutically equivalent to Wegovy, Ozempic, Zepbound, or Mounjaro. Injection-site reaction rates cited are from trials of the branded molecules; individual experiences vary. If you have signs of a serious allergic reaction — face or throat swelling or trouble breathing — call 911. Nouri connects patients with licensed, independent physicians who make all prescribing decisions.